NASDAQ:NAMSW

NewAmsterdam Pharma (NAMSW) Stock Price, News & Analysis

NewAmsterdam Pharma logo
$9.30 -0.19 (-2.00%)
Closing price 11/16/2026 03:59 AM Eastern
Extended Trading
$9.30 0.00 (0.00%)
As of 11/16/2026 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About NewAmsterdam Pharma Stock (NASDAQ:NAMSW)

Advanced

Key Stats

Today's Range
$9.49
▼
$9.49
50-Day Range
$8.38
▼
$14.49
52-Week Range
$7.31
▼
$30.45
Volume
N/A
Average Volume
2,138 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NewAmsterdam Pharma is a clinical-stage biopharmaceutical company focused on developing oral medicines for people with cardiovascular and metabolic diseases. Its research centers on treatments to lower LDL cholesterol and address cardiovascular risk, particularly for patients who need additional options alongside existing therapies.

The company’s lead candidate, obicetrapib, is an investigational oral cholesterol-lowering medicine that inhibits CETP, a protein involved in lipid metabolism. NewAmsterdam has also studied obicetrapib in combination with ezetimibe. These treatments are under development and are not described here as approved or commercially available products.

NewAmsterdam Pharma is based in Naarden, the Netherlands. Michael Davidson, a physician and lipid specialist, has served as the company’s chief executive officer.

AI Generated. May Contain Errors.

Receive NAMSW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NAMSW Stock News Headlines

Top Trader Reveals Stunning Black Friday Deal
Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel
NewAmsterdam Pharma: Potential Coupled With Uncertainty
See More Headlines

NAMSW Stock Analysis - Frequently Asked Questions

NewAmsterdam Pharma's stock was trading at $22.99 at the beginning of 2026. Since then, NAMSW stock has decreased by 59.5% and is now trading at $9.30.

Top institutional shareholders of NewAmsterdam Pharma include RA Capital Management L.P..

Shares of NAMSW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:NAMSW
CIK
1936258
Fax
N/A
Employees
100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$25.94 million
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:NAMSW) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners